471 related articles for article (PubMed ID: 8362983)
1. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
[TBL] [Abstract][Full Text] [Related]
2. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
[TBL] [Abstract][Full Text] [Related]
4. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells.
Midorikawa S; Sanada H; Hashimoto S; Watanabe T
Biochem Biophys Res Commun; 2000 May; 272(1):182-5. PubMed ID: 10872824
[TBL] [Abstract][Full Text] [Related]
5. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis.
Jung HS; Park KH; Cho YM; Chung SS; Cho HJ; Cho SY; Kim SJ; Kim SY; Lee HK; Park KS
Cardiovasc Res; 2006 Jan; 69(1):76-85. PubMed ID: 16271710
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls.
Chomiki N; Henry M; Alessi MC; Anfosso F; Juhan-Vague I
Thromb Haemost; 1994 Jul; 72(1):44-53. PubMed ID: 7974374
[TBL] [Abstract][Full Text] [Related]
7. [Effect of PAI-1 antisense RNA on vascular endothelial growth factor expression in aorta smooth muscle cells cultured in vitro].
Fu L; Mei Y; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):110-3. PubMed ID: 11295128
[TBL] [Abstract][Full Text] [Related]
8. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
Christ G; Hufnagl P; Kaun C; Mundigler G; Laufer G; Huber K; Wojta J; Binder BR
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):723-30. PubMed ID: 9108786
[TBL] [Abstract][Full Text] [Related]
9. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
Ueshima S; Fukao H; Okada K; Matsuo O
Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564
[TBL] [Abstract][Full Text] [Related]
11. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
Dodge AB; Lu X; D'Amore PA
J Cell Biochem; 1993 Sep; 53(1):21-31. PubMed ID: 8227180
[TBL] [Abstract][Full Text] [Related]
12. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques.
Tipping PG; Hancock WW
Am J Pathol; 1993 Jun; 142(6):1721-8. PubMed ID: 8506944
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
Cullen JP; Nicholl SM; Sayeed S; Sitzmann JV; Okada SS; Cahill PA; Redmond EM
Thromb Res; 2004; 114(1):57-65. PubMed ID: 15262486
[TBL] [Abstract][Full Text] [Related]
14. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
Nordt TK; Lutzi S; Ruef J; Peter K; Klar E; Kübler W; Sobel BE; Bode C
Thromb Haemost; 2001 Nov; 86(5):1305-13. PubMed ID: 11816722
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
Blei F; Wilson EL; Mignatti P; Rifkin DB
J Cell Physiol; 1993 Jun; 155(3):568-78. PubMed ID: 7684043
[TBL] [Abstract][Full Text] [Related]
16. Release of soluble urokinase receptor from vascular cells.
Chavakis T; Willuweit AK; Lupu F; Preissner KT; Kanse SM
Thromb Haemost; 2001 Aug; 86(2):686-93. PubMed ID: 11522023
[TBL] [Abstract][Full Text] [Related]
17. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Dichtl W; Ares MP; Stollenwerk M; Giachelli CM; Scatena M; Hamsten A; Eriksson P; Nilsson J
Thromb Haemost; 2000 Oct; 84(4):706-11. PubMed ID: 11057874
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.
Nordt TK; Peter K; Bode C; Sobel BE
J Clin Endocrinol Metab; 2000 Apr; 85(4):1563-8. PubMed ID: 10770198
[TBL] [Abstract][Full Text] [Related]
19. Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery.
Zhang WJ; Wojta J; Binder BR
Cell Mol Biol (Noisy-le-grand); 1997 Jun; 43(4):581-7. PubMed ID: 9220151
[TBL] [Abstract][Full Text] [Related]
20. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
